Business
Dec 10, 2025 · Cgkik

CVS forecasts 2026 profit above estimates on strong performance

Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above ​Wall Street estimates and this ‌year's projected earnings, signalling steady progress in the ‌health conglomerate's turnaround plan.

CVS stock rose 5% in early trading on Tuesday.

The company in October projected double-digit earnings growth for 2026 after raising its 2025 ⁠profit forecast for ‌the third time.

"We are closing out 2025 with meaningful ‍momentum across our businesses and we expect another year of strong earnings growth in ​2026," said Chief Financial Officer ‌Brian Newman on Tuesday.

The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, ⁠according to data compiled ​by LSEG.

It, however, ​expects total revenue of at least $400 billion next year, below analysts' ‍average estimate ⁠of $419.26 billion.

Yahoo Finance Breaking News
By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy

CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 ⁠per share from $6.55 to $6.65 previously.

(Reporting by Sneha ‌S K in Bengaluru; Editing ‌by Shinjini Ganguli)

You Might Also Like

News

Atorvastatin recall may affect hundreds of thousands of patients – and reflects FDA’s troubles inspecting medicines manufactured overseas

News

They relied on marijuana to get through the day. But then days felt impossible without it

News

Zelensky sees win for Ukraine as EU finally reaches funding deal

News

Parents search for children missing since a volcanic eruption in Colombia 40 years ago